ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: MSKCC Launches Molecular Oncology, Genomic Center

May 23, 2014

NIH Director Varmus Names President of Sloan-Kettering, Succeeding Mark

October 15, 1999

NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said

June 24, 1994

Four NCAB Appointments Announced, Including Durant, Fisher; White House Delays On Others

April 4, 1986

Clinton Declares Month of April Cancer Control Month

April 11, 1997

Georgetown-Hackensack Consortium Plan Points to Rising Value of NCI Designation

April 19, 2013